Category

News

Cytodigm Announces Breakthrough Study Published in Science Advances: Enhancing Glioblastoma Treatment

Boston, MA, April 16, 2025 – Cytodigm, a leader in advanced nanoparticle delivery systems, in collaboration...

Cytodigm to Present at In Vivo Cell Engineering

On June 4, 2025, in Boston, Dr. Bin Wu, Founder and CEO of Cytodigm, will present “Exploring Treatment...

Cytodigm to Present at ASCGT

On May 16, 2025, in New Orleans, LA, Dr. Bin Wu, Founder and CEO of Cytodigm, will present “Leveraging...

Cytodigm to Present at 4th Extrahepatic LNP Summit

In Boston, on June 25, 2025, Dr. Bin Wu, Cytodigm’s Founder and CEO, will present “Redefining...

Cytodigm Presents at LNP Immunogenicity Summit

Dr. Bin Wu, our Founder and CEO, recently delivered a compelling presentation at the 3rd LNP Immunogenicity...

January 6, 2025

Cytodigm to Present at 3rd Annual LNP Immunogenicity & Toxicity Summit

In Boston, on December 11, 2024, Dr. Bin Wu, Cytodigm’s Founder and CEO, will present “Case Study:...

December 11, 2024

Cytodigm and Cour Sign Licensing Deal

Natick, MA, February 6, 2024 – Cytodigm, a biopharmaceutical company developing innovative delivery...

February 6, 2024

Cytodigm Introduces Its PEG-Free Lipid Nanoparticles at LNP Summit

Boston, MA, December 11, 2023 – Victoria Trantow, R&D Scientist at Cytodigm, presented a poster titled...

December 11, 2023